You are here: Home » News-CM » Companies » Results
Business Standard

Vivo Bio Tech standalone net profit declines 24.14% in the March 2017 quarter

Capital Market 

Sales rise 16.33% to Rs 8.55 crore

Net profit of declined 24.14% to Rs 0.22 crore in the quarter ended March 2017 as against Rs 0.29 crore during the previous quarter ended March 2016. Sales rose 16.33% to Rs 8.55 crore in the quarter ended March 2017 as against Rs 7.35 crore during the previous quarter ended March 2016.

For the full year,net profit rose 174.73% to Rs 2.50 crore in the year ended March 2017 as against Rs 0.91 crore during the previous year ended March 2016. Sales rose 12.62% to Rs 32.12 crore in the year ended March 2017 as against Rs 28.52 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales8.557.35 16 32.1228.52 13 OPM %18.018.98 -23.7213.01 - PBDT1.050.82 28 6.734.13 63 PBT-0.05-0.10 50 2.830.78 263 NP0.220.29 -24 2.500.91 175

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Sat, May 20 2017. 17:23 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU